Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma
Authors:
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 101 (3) , 628-637
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Once-daily evening administration of mometasone furoate in asthma treatment initiationAnnals of Allergy, Asthma & Immunology, 2006
- Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhalerAnnals of Allergy, Asthma & Immunology, 2001
- Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthmaJournal of Allergy and Clinical Immunology, 2000
- Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthmaJournal of Allergy and Clinical Immunology, 2000
- Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthmaAnnals of Allergy, Asthma & Immunology, 2000
- Glucocorticoids Inhibit Proliferation and Interleukin-4 and Interleukin-5 Secretion by Aeroallergen-Specific T-Helper Type 2 Cell LinesAnnals of Allergy, Asthma & Immunology, 1998
- The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-γ production by cultured primary CD4+ T cells☆☆☆★★★Journal of Allergy and Clinical Immunology, 1997
- Fluticasone Propionate Reduces Oral Prednisone Use While It Improves Asthma Control and Quality of LifeAmerican Journal of Respiratory and Critical Care Medicine, 1995
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- A scale for the measurement of quality of life in adults with asthmaJournal of Clinical Epidemiology, 1992